Makoto Ueno

Yokohama, JP

Expertise in

conditions

Yokohama, JP

Overview

Makoto Ueno practices in Yokohama, Japan. Mr. Ueno is highly rated in 12 conditions, according to our data. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.

His clinical research consists of co-authoring 257 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Yokohama, Japan

Other Locations

Tokyo, Japan

Shinjuku, 1608582, Japan

Kanazawa, Japan

Kanagawa, Japan

Shizuoka, 4118777, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase II/III, Multicenter, Randomized, Placebo-controlled Study of Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) as First-line Treatment of Biliary Tract Cancer

Enrollment Status: Terminated

Publish Date: November 14, 2023

Intervention Type: Drug

Study Drugs: Bintrafusp Alfa, Gemcitabine, Cisplatin

Study Phase: Phase 2/Phase 3

A Phase II, Multicenter, Open-label Study to Investigate the Clinical Efficacy of M7824 Monotherapy in Participants With Locally Advanced or Metastatic Biliary Tract Cancer Who Fail or Are Intolerant to First-line Platinum-Based Chemotherapy

Enrollment Status: Completed

Publish Date: October 25, 2023

Intervention Type: Drug

Study Drug: M7824

Study Phase: Phase 2

View 1 Less Clinical Trial

257 Total Publications

Eosinophilic cholangitis mimicking IgG4-related sclerosing cholangitis in an older female patient.

Journal: Immunological medicine

Published: March 27, 2026

View All 257 Publications

Frequently Asked Questions about Makoto Ueno

Is Makoto Ueno a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Makoto Ueno is classified as an Elite expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Makoto Ueno participate in research or clinical trials?

Yes. Makoto Ueno has published 257 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Makoto Ueno's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ueno's expertise for a condition

ConditionClose